Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme
Condition(s):GlioblastomaLast Updated:July 1, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):GlioblastomaLast Updated:July 1, 2019Terminated
Condition(s):HIV InfectionsLast Updated:December 14, 2016Terminated
Condition(s):HIV InfectionsLast Updated:February 26, 2014Completed
Condition(s):MesotheliomaLast Updated:February 1, 2024Completed
Condition(s):Multiple Sclerosis; Neuromyelitis OpticaLast Updated:February 27, 2020Completed
Condition(s):Malignant Melanoma Stage IVLast Updated:July 8, 2013Terminated
Condition(s):Lymphoma; Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 19, 2019Completed
Condition(s):Multiple MyelomaLast Updated:June 22, 2023Active, not recruiting
Condition(s):de Novo GlioblastomaLast Updated:September 12, 2019Completed
Condition(s):Prostate CancerLast Updated:January 21, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.